We provide integrated preclinical research solutions designed to support the full spectrum of product evaluation. From early-stage screening to efficacy, safety, and mechanistic assessment.
Human cell-based platforms used for targeted biological investigations and early-stage screening studies.
We are leading the way with Hybrid Diffuse Reflectance Spectroscopy (HDRS) — the latest non-invasive SPF testing method that delivers accurate results in seconds. With no UV exposure, it offers a safer, faster, and more precise approach to SPF evaluation. Our pioneering work in validating HDRS for darker skin tones (Skin of Colour) sets a new global standard for inclusive and innovative SPF testing.
A wide range of skin parameters can be assessed, depending on the study objective and product category.
Every study is led by expert dermatologists and supported by extensive assessment infrastructure, from instrumental analysis to imaging systems.
supporting stat
Studies can be paired with advanced instrumental evaluation systems including spectrophotometric analysis, skin imaging and texture analysis, hydration measurement, skin impedance evaluation, and UV response assessment.
Link comes hereIntegrated biological evaluation capabilities include cytokine analysis, protein expression studies, growth factor assessment, biomarker-based evaluation, inflammatory marker analysis, and molecular response assessment.
Support for both injectable and topical applications across ex vivo platforms enables expanded formulation and delivery assessment.
Research platforms can be integrated with procedure-based studies to support broader translational and comparative evaluation workflows.
Partnership with MatTek since 2019 strengthens access to advanced reconstructed human tissue models and globally aligned tissue-based research platforms.
